Abiopharma

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation

Notification regarding unquoted securities - MSB

Application for quotation of securities - MSB

Appendix 3Y for Eric Rose

argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG

AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans

ResMed Inc. Daily Stock Update

AGL ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of agilon Investors

SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.